Literature DB >> 21468040

Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine.

R Itzykson, S Thépot, V Eclache, B Quesnel, F Dreyfus, O Beyne-Rauzy, P Turlure, N Vey, C Recher, S Boehrer, C Gardin, L Adès, P Fenaux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21468040     DOI： 10.1038/leu.2011.63

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

Review 1.  Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel.

Authors:  Theo de Witte; David Bowen; Marie Robin; Luca Malcovati; Dietger Niederwieser; Ibrahim Yakoub-Agha; Ghulam J Mufti; Pierre Fenaux; Guillermo Sanz; Rodrigo Martino; Emilio Paolo Alessandrino; Francesco Onida; Argiris Symeonidis; Jakob Passweg; Guido Kobbe; Arnold Ganser; Uwe Platzbecker; Jürgen Finke; Michel van Gelder; Arjan A van de Loosdrecht; Per Ljungman; Reinhard Stauder; Liisa Volin; H Joachim Deeg; Corey Cutler; Wael Saber; Richard Champlin; Sergio Giralt; Claudio Anasetti; Nicolaus Kröger
Journal:  Blood       Date:  2017-01-17       Impact factor: 22.113

2.  Specific abnormalities versus number of abnormalities and cytogenetic scoring systems for outcome prediction after allogeneic hematopoietic SCT for myelodysplastic syndromes.

Authors:  C Kelaidi; I Tzannou; I Baltadakis; I Batsis; D Mallouri; A Spyridonidis; S Gigantes; P Tsirigotis; I Apostolidis; A Athanasiadou; K Manola; A Anagnostopoulos; N Harhalakis; I Sakellari; D Karakasis
Journal:  Bone Marrow Transplant       Date:  2014-05-05       Impact factor: 5.483

3.  Hematopoietic Cell Transplantation in Myelodysplastic Syndromes after Treatment with Hypomethylating Agents.

Authors:  Moreno Festuccia; Kelsey Baker; Theodore A Gooley; Brenda M Sandmaier; H Joachim Deeg; Bart L Scott
Journal:  Biol Blood Marrow Transplant       Date:  2017-06-30       Impact factor: 5.742

4.  Oncolytic virotherapy for hematological malignancies.

Authors:  Swarna Bais; Eric Bartee; Masmudur M Rahman; Grant McFadden; Christopher R Cogle
Journal:  Adv Virol       Date:  2011-10-29

5.  Monosomal and complex karyotypes as prognostic parameters in patients with International Prognostic Scoring System higher risk myelodysplastic syndrome treated with azacitidine.

Authors:  Kyung-Lim Hwang; Moo-Kon Song; Ho-Jin Shin; Hae-Jung Na; Dong-Hun Shin; Joong-Keun Kim; Joon-Ho Moon; Jae-Sook Ahn; Ik-Chan Song; Junshik Hong; Gyeong-Won Lee; Joo-Seop Chung
Journal:  Blood Res       Date:  2014-12-23

6.  Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004.

Authors:  M Rasche; C von Neuhoff; M Dworzak; J-P Bourquin; J Bradtke; G Göhring; G Escherich; G Fleischhack; N Graf; B Gruhn; O A Haas; T Klingebiel; B Kremens; T Lehrnbecher; A von Stackelberg; J Tchinda; Z Zemanova; C Thiede; N von Neuhoff; M Zimmermann; U Creutzig; D Reinhardt
Journal:  Leukemia       Date:  2017-04-25       Impact factor: 11.528

Review 7.  Monosomal karyotype in myeloid neoplasias: a literature review.

Authors:  Luisa Anelli; Crescenza Pasciolla; Antonella Zagaria; Giorgina Specchia; Francesco Albano
Journal:  Onco Targets Ther       Date:  2017-04-20       Impact factor: 4.147

8.  TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups.

Authors:  Detlef Haase; Kristen E Stevenson; Donna Neuberg; Jaroslaw P Maciejewski; Aziz Nazha; Mikkael A Sekeres; Benjamin L Ebert; Guillermo Garcia-Manero; Claudia Haferlach; Torsten Haferlach; Wolfgang Kern; Seishi Ogawa; Yasunobu Nagata; Kenichi Yoshida; Timothy A Graubert; Matthew J Walter; Alan F List; Rami S Komrokji; Eric Padron; David Sallman; Elli Papaemmanuil; Peter J Campbell; Michael R Savona; Adam Seegmiller; Lionel Adès; Pierre Fenaux; Lee-Yung Shih; David Bowen; Michael J Groves; Sudhir Tauro; Michaela Fontenay; Olivier Kosmider; Michal Bar-Natan; David Steensma; Richard Stone; Michael Heuser; Felicitas Thol; Mario Cazzola; Luca Malcovati; Aly Karsan; Christina Ganster; Eva Hellström-Lindberg; Jacqueline Boultwood; Andrea Pellagatti; Valeria Santini; Lynn Quek; Paresh Vyas; Heinz Tüchler; Peter L Greenberg; Rafael Bejar
Journal:  Leukemia       Date:  2019-01-11       Impact factor: 12.883
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.